Our board
The Thiscovery board includes senior members of THIS Institute and The Health Foundation, alongside non-executives with backgrounds in healthcare and social impact.
Mary Dixon-Woods is Director of THIS Institute and The Health Foundation Professor of Healthcare Improvement Studies at the University of Cambridge.
A Professorial Fellow at Homerton College, she is a fellow of the Academy of Social Sciences and the Academy of Medical Sciences, and an honorary fellow of the Royal College of Physicians, Royal College of General Practitioners, and Royal College of Obstetricians and Gynaecologists.
Mary was an NIHR Senior Investigator (2017-2022) and served on the National Advisory Group on the Safety of Patients in England, contributing to the 2013 Berwick report. Mary was also a Wellcome Trust Senior Investigator (2012-2019) and the 2018 Harveian Orator for the Royal College of Physicians. She is a member of the BMJ’s international advisory board.
Jag is Chair of Royal Papworth Hospital, as of February 2024, having served as a Non-Executive Director since 2019. He is also a Director of Cambridge University Health Partners.
He trained in medicine at Cambridge and London, qualifying in 1986, with postgraduate training in general practice, paediatrics, and neonatology. Jag was appointed consultant neonatologist at Cambridge in 1996, where he also directed the neonatal service for many years. He held leadership roles, including nearly 10 years as Executive Medical Director at Cambridge University Hospitals (CUH) NHS Foundation Trust, with responsibilities including professional governance, research, education, infection control and patient safety.
Jag also served as Director of Digital at CUH, leading IT development, and chaired the Cambridgeshire and Peterborough STP digital group.
In his clinical role, he was a senior officer at the British Association of Perinatal Medicine, network lead for the Norfolk, Suffolk and Cambridgeshire neonatal network and chair of the East of England Medical Directors Forum.
Jag is also a trustee of Macmillan Cancer Support and an Honorary Fellow of the Cambridge Judge Business School.
Ingeborg is an experienced scale-up CFO in MedTech and climate tech, focused on helping ambitious businesses grow so their solutions can benefit as many people as possible and have a positive impact on our planet.
Ingeborg started her career at Goldman Sachs focusing on medical devices and healthcare services before moving into more commercial and operations finance roles.
She holds an MEng in Biomedical Engineering from Imperial College and has a master in Public Health. She is a CFA charterholder.
Richard Lewis is a strategy consultant and evaluator who specialises in the health and care sector. Until 2018 he was a partner at Ernst & Young LLP, leading their health advisory practice in the UK and Ireland.
Richard’s background includes time spent seconded to government - as a health team leader in the Prime Minister’s Delivery Unit and later supporting the primary and community care elements of Lord Darzi’s NHS Next Stage Review in 2008. Prior to this, he was a Senior Fellow at the King’s Fund and began his career in the NHS working at regional level and at board level as a director of commissioning in London.
Richard has a longstanding interest in health system reform care and has published and researched in this area for nearly 30 years. He co-led the national evaluation of integrated care pilots for the Department of Health.
Richard has a PhD in health policy implementation and is a Visiting Senior Fellow at the Nuffield Trust, a trustee of Bart’s Charity and Vice Chair (Strategy) for Helpforce, the national charity supporting volunteering in health and care.
Dr Emma Salgård Cunha is Associate Director in the Technology Development and Licensing team at Cambridge Enterprise, the innovation arm of the University of Cambridge. Emma leads Cambridge’s support for innovation and enterprise projects emerging from research in social science disciplines.
With special interests in software commercialisation and social enterprise, Emma has supported dozens of university enterprises developing evidence-based approaches in a broad range of sectors: from creative industries to public health to global development to financial services.
A literary historian by training, Emma holds a PhD from the University of Cambridge.
